A handful of initial public offerings are expected to be a litmus test as more companies consider going public. In other news from the intersection of health care and technology, the VA to spend billions to maintain its current EHR system through a transition to Cerner, a medicine company plans a comeback, the questionable motives at the heart of a hospital's offer from free screenings, and more.
from Kaiser Health News https://ift.tt/2K8YGb6
July 26, 2019
Rose
Health News, Kaiser Health News
No comments
Related Posts:
How the Test-to-Treat Pillar of the US Covid Strategy Is Failing PatientsThe federal “test-to-treat” program, announced in March, is meant to reduce covid hospitalizations and deaths by quickly getting antiviral pills to people who test positive. But even as cases rise again, many Americans don’t … Read More
Battle Lines Are Drawn Over California Deal With Kaiser Permanente[Editor’s note: KHN is not affiliated with Kaiser Permanente.] California counties, health insurance plans, community clinics, and a major national health care labor union are lining up against a controversial deal to gr… Read More
Journalist Puts in a Plug for Better Sleep Cycles During the PandemicKHN assistant social media manager Krishna Sharma discussed how work flexibility can help overcome some sleep problems on Newsy on April 14. Click here to watch Sharma on Newsy Read Sharma’s “Losing Sleep Over the Pandemic? … Read More
Attendance Plummets at LA Covid Vaccination EventsLOS ANGELES — Nurse Angel Ho-king sways her head to the sound of salsa music as she waits for people willing to roll up their sleeves to get a shot. Ho-king is part of a four-person crew staffing a covid-19 vaccine table at a… Read More
Washington State Retools First-in-the-Nation Long-Term Care BenefitPatricia Keys, 71 and a stroke survivor, needs help with many everyday activities, such as dressing and bathing. Her daughter Christina, who lives near her mom in Vancouver, Washington, cares for her in the evenings and pays … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment